TORONTO, March 16, 2021 (GLOBE NEWSWIRE) — Canada’s main supplier of medical CBD (cannabidiol) and different cannabinoids, Toronto-based Cannalogue has introduced it’s now accepting requests for medical trials and analysis with medical CBD. Cannalogue is allowed to facilitate the research of medical merchandise in a real-world medical analysis setting and is welcoming expressions of curiosity from firms with authorized medical CBD merchandise.
In an effort to speed up medical CBD analysis efforts, and to concurrently present high-quality information to regulatory our bodies resembling Well being Canada and the U.S. Meals and Drug Administration (FDA), Cannalogue will supply recruitment and analysis for a variety of situations together with persistent ache, nervousness, sleep points, and pores and skin issues. Further situations for research may also be evaluated upon request.
“Given the complexity of the medical trials and analysis course of, Cannalogue’s specialised data permits us to carry out a variety of duties on behalf of licensed producers and processors,” says Dr. Mohan Cooray, President and CEO of Cannalogue. “Our hope is to assist thousands and thousands of sufferers the world over with our findings and to deal with gaps in conventional medication with these new plant-derived medicines,” he says.
Researchers and scientists, educational establishments, docs and clinics, medical associations, athletic associations, hospitals, pharmaceutical producers, insurance coverage suppliers, well being businesses, FDAs, governments, and different worldwide our bodies trying to take part in analysis are suggested to contact Cannalogue.
For extra detailed data together with eligibility standards, please go to www.cannalogue.ca/research
Media Contact: Melanie Greco 647-456-2653